Literature DB >> 28546043

Mynx Vascular Closure Device in Arterial Endovascular Procedures.

Michael C Scott1, Horace J Spencer1, Ahsan T Ali2, Mohammed M Moursi2, Guillermo A Escobar2, Lewis C Lyons2, Matthew R Smeds3.   

Abstract

BACKGROUND: Vascular closure devices have been used to achieve hemostasis of percutaneous access sites following endovascular procedures, with reported decreased time for arterial control as well as decreased time to ambulation. We sought to determine rates and risk factors of postoperative bleeding complications and failures using these devices from a single institution experienced in the use of vascular closure devices.
METHODS: All patients undergoing arterial endovascular procedures with percutaneous access between March 2010 and October 2015 at a single institution were identified and analyzed (n = 894). Patients undergoing endovascular aneurysm repair, open access, venous procedures, or upper extremity access were excluded. Comparison groups were formed between those using the Mynxgrip® (Mynx), Angio-Seal™, Perclose® vascular closure devices and manual pressure (MP). Patient demographics, intraoperative data, and postoperative complications were compared.
RESULTS: A total of 615 (69%) patients received Mynx, 165 other vascular closure devices (VCD) ([14%] Perclose, 44 [4%] Angio-Seal), and 114 (13%) MP. MP patients were more likely to be diagnostic angiogram with smaller sheaths, while VCD patients were more likely to be interventions with larger sheaths. Univariate analysis identified age, atrial fibrillation, intervention (as opposed to diagnostic), and sheath size >5F associated with postoperative bleeding (P < 0.05), and in backward, logistic regression analysis, sheath size, age, and renal failure were independent predictors of the same.
CONCLUSIONS: Use of vascular closure devices has a low rate of bleeding complication, device failure, and need for operative repair. Bleeding is associated with increased age, interventional procedure, and end-stage renal disease. Mynx, Perclose, and Angio-Seal have similar rates of complications. Use of these devices are a safe option for groin vessel closure.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28546043     DOI: 10.1016/j.avsg.2017.05.009

Source DB:  PubMed          Journal:  Ann Vasc Surg        ISSN: 0890-5096            Impact factor:   1.466


  3 in total

1.  Hemostasis After Brachial Artery Access With the MynxGrip Device: A Case Report.

Authors:  Arturo Giordano; Stefano Messina; Gennaro Maresca; Giuseppe Biondi-Zoccai
Journal:  Clin Med Insights Cardiol       Date:  2018-02-20

2.  Comparison of MynxGrip vascular closure device and manual compression for closure after femoral access angiography: a randomized controlled trial: the closure devices used in every day practice study, CLOSE-UP III trial.

Authors:  Lars Jakobsen; Niels R Holm; Michael Maeng; Troels Thim; Steen D Kristensen; Lone H Mogensen; Evald H Christiansen
Journal:  BMC Cardiovasc Disord       Date:  2022-02-23       Impact factor: 2.298

3.  Endovascular repair of a common femoral artery puncture after losing access using a vascular closure device.

Authors:  Vamsi Reddy; Nathan Todnem; Camila Franco-Mesa; Young Erben; Rabih G Tawk; Charles Ritchie
Journal:  J Vasc Surg Cases Innov Tech       Date:  2021-05-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.